Search

everythinglearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.

Steroid hormones change the size, charge, and stability of DPPC liposomes.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

FOL-026 peptide can help repair blood vessels and promote growth, offering potential treatment for vascular diseases.

PPARα agonists may help treat alopecia areata by reducing inflammation.

GLP-1 agonists may help treat certain skin conditions.

PPARs help regulate skin health and could be used to treat skin disorders.

Cubosomes enhance antimicrobial peptide stability and effectiveness.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

A cholesterol-free liposomal platform using protopanaxadiol effectively promotes hair growth and treats alopecia.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Phospholipids help plant proteins move by regulating receptor interactions.

Lipid nanoparticles improve treatment delivery and are key to future therapies, but challenges in manufacturing and safety remain.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

New research on prostamide F2α has led to treatments for glaucoma and eyelash growth and may have more medical uses.

Liposomes can improve the effectiveness of skin treatments.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

New anti-acne medications are being tested to offer alternatives to current treatments.

Solid lipid nanoparticles are promising for safe and effective drug delivery but need more research for clinical use.

Drugs targeting EMT molecules show promise for treating lichen planopilaris.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

The new gel for psoriasis is effective, stable, and easy to apply.

Targeting lipid metabolism can help treat advanced, resistant cancers.

Solid lipid nanoparticles are promising for delivering various drugs and improving treatment effectiveness.

The new gel effectively treats psoriasis with minimal side effects.